top_cornerHomeEMD-8573  Contact EMDataBank 
Image unavailable
Title:HIV-1 CH505 Transmitted Founder SOSIP.664 Env trimer in Complex with the DH576 Fab from the RV305 Trial
Authors:Fera D, Harrison SC
Sample:HIV-1 CH505 Transmitted Founder SOSIP.664 Env trimer in Complex with the DH576 Fab from the RV305 Trial
Method:Single particle reconstruction (28.1 angstroms resolution)
Summary
Status: Released
Deposition date: 2017-01-23
Deposition site: RCSB
Processing site: RCSB
Header release date: 2017-02-15
Map release date: 2017-03-08
Primary citation: Boosting of HIV envelope CD4 binding site antibodies with long variable heavy third complementarity determining region in the randomized double blind RV305 HIV-1 vaccine trial.
Easterhoff D, Moody MA, Fera D, Cheng H, Ackerman M, Wiehe K, Saunders KO, Pollara J, Vandergrift N, Parks R, Kim J, Michael NL, O'Connell RJ, Excler JL, Robb ML, Vasan S, Rerks-Ngarm S, Kaewkungwal J, Pitisuttithum P, Nitayaphan S, Sinangil F, Tartaglia J, Phogat S, Kepler TB, Alam SM, Liao HX, Ferrari G, Seaman MS, Montefiori DC, Tomaras GD, Harrison SC, Haynes BF
PLoS Pathog. (2017) 13, pp. e1006182-e1006182 [PubMed 28235027] [DOI]
Sample: HIV-1 CH505 Transmitted Founder SOSIP.664 Env trimer in Complex with the DH576 Fab from the RV305 Trial
Resolution: 28.1 Å (determined by FSC 0.5 CUT-OFF)